MMED logo

MINIMED GROUP INC

MMEDNASDAQ
🏆 #1213 by market capUS Equity
$20.03▼ $0.46 (−2.29%)
After hours · at close
🔔
Track MMED
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 2.3%
7d▼ 5.5%
14d▼ 9.0%
30d▼ 0.3%
ytd—
1y—
🏦Market Cap
$5.62B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
84
Good

Trading Snapshot

Day Range
$19.73 – $20.23
52-Week Range
$10.65 – $24.43
Volume
$2.91B
Avg Volume
$2.62B
Shares Outstanding
280.8M
Next Earnings
Oct 20, 2026

Fundamentals Snapshot

Annual Revenue
$3.10B
Last Q Revenue
$843M
P/E Ratio
—
P/S Ratio
—
EPS (TTM)
—
Dividend Yield
—
Dilution (1yr)
+0.0%

Why Investors Own MMED

  • ✓High-growth profile — revenue up +39.6% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 51% gross margin and 20% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MMED logo

MINIMED GROUP INC

MMED
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3.1B▲ +14.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
54.2%▼ −3.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$49M▼ −124.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$420M▲ +692.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
281.0M▲ +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$148M▼ −$202M YoY
StockOtter · stockotter.space

About MINIMED GROUP INC

MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
84/100

Analyst Price Target

ⓘ
Average Target
$20.95
▲ +4.6% Upside
High Target$23.32
Low Target$18.86
Based on 12 analysts

Latest News & Updates

🚀
Barron’s·2h ago

MINIMED GROUP INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift MMED price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

MINIMED GROUP INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.